Literature DB >> 17475845

Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules.

Xiuxu Chen1, Xiaohua Wang, Jason M Keaton, Faye Reddington, Petr A Illarionov, Gurdyal S Besra, Jenny E Gumperz.   

Abstract

CD1d molecules present both self Ags and microbial lipids to NKT cells. Previous studies have established that CD1d lysosomal trafficking is required for presentation of autoantigens to murine invariant NKT cells. We show in this study that this is not necessary for autoantigen presentation by human CD1d, but significantly affects the presentation of exogenous Ags. Wild-type and tail-deleted CD1d molecules stimulated similar autoreactive responses by human NKT clones, whereas presentation of exogenous lipids by tail-deleted CD1d was highly inefficient. Chloroquine treatment markedly inhibited exogenous Ag presentation by wild-type CD1d transfectants, but did not affect NKT autoreactive responses. Conversely, APC expression of HLA-DRalphabeta and the invariant chain (Ii) was associated with faster internalization of CD1d into the endocytic system and enhanced CD1d-mediated presentation of exogenous Ags, but did not appear to augment NKT autoreactivity. Knockdown of the Ii by small interfering RNA resulted in reduced CD1d surface expression and slower internalization in HLA-DR+ APCs, but not HLA-DR- APCs, demonstrating a direct effect of MHC/Ii complexes on CD1d trafficking. CD1d-mediated presentation of exogenous Ags was much more efficient in immature dendritic cells, which actively recycle MHC class II molecules through the endocytic system, than in mature dendritic cells that have stabilized MHC class II expression at the cell surface, suggesting a physiological role for MHC/Ii complexes in modulating CD1d function. These results indicate that autoantigens and exogenous lipids are acquired by human CD1d at distinct cellular locations, and that Ii trafficking selectively regulates CD1d-mediated presentation of extracellular Ags.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475845     DOI: 10.4049/jimmunol.178.10.6181

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

2.  Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.

Authors:  Bo Pei; Anneliese O Speak; Dawn Shepherd; Terry Butters; Vincenzo Cerundolo; Frances M Platt; Mitchell Kronenberg
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

3.  Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

Authors:  Lisa M Fox; Jennifer Miksanek; Nathan A May; Louise Scharf; Jennifer L Lockridge; Natacha Veerapen; Gurdyal S Besra; Erin J Adams; Amy W Hudson; Jenny E Gumperz
Journal:  Cancer Immun       Date:  2013-05-10

Review 4.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

Review 5.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

6.  Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.

Authors:  Sebastian Zeissig; Stephanie K Dougan; Duarte C Barral; Yvonne Junker; Zhangguo Chen; Arthur Kaser; Madelyn Ho; Hannah Mandel; Adam McIntyre; Susan M Kennedy; Gavin F Painter; Natacha Veerapen; Gurdyal S Besra; Vincenzo Cerundolo; Simon Yue; Sarah Beladi; Samuel M Behar; Xiuxu Chen; Jenny E Gumperz; Karine Breckpot; Anna Raper; Amanda Baer; Mark A Exley; Robert A Hegele; Marina Cuchel; Daniel J Rader; Nicholas O Davidson; Richard S Blumberg
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

Review 7.  Natural Killer T cell obsession with self-antigens.

Authors:  Laurent Gapin; Dale I Godfrey; Jamie Rossjohn
Journal:  Curr Opin Immunol       Date:  2013-02-04       Impact factor: 7.486

8.  Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.

Authors:  Gediminas Matulis; Joseph P Sanderson; Nikolai M Lissin; Maria B Asparuhova; Gopal R Bommineni; Daniel Schümperli; Richard R Schmidt; Peter M Villiger; Bent K Jakobsen; Stephan D Gadola
Journal:  PLoS Biol       Date:  2010-06-22       Impact factor: 8.029

9.  Linking inflammation to natural killer T cell activation.

Authors:  Mariolina Salio; Vincenzo Cerundolo
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

10.  Recognition of lyso-phospholipids by human natural killer T lymphocytes.

Authors:  Lisa M Fox; Daryl G Cox; Jennifer L Lockridge; Xiaohua Wang; Xiuxu Chen; Louise Scharf; David L Trott; Rachel M Ndonye; Natacha Veerapen; Gurdyal S Besra; Amy R Howell; Mark E Cook; Erin J Adams; William H Hildebrand; Jenny E Gumperz
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.